KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.

The promising results of anaplastic lymphoma kinase (ALK) inhibitors have changed the significance of ALK fusions in several types of cancer. These fusions are no longer mere research targets or diagnostic markers, but they are now directly linked to the therapeutic benefit of patients. However, mos...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yuki Togashi, Manabu Soda, Seiji Sakata, Emiko Sugawara, Satoko Hatano, Reimi Asaka, Takashi Nakajima, Hiroyuki Mano, Kengo Takeuchi
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/3cd968b320cf479fb7e56c68f8941206
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!